Remarkably, in patients with ER + breast cancer, elevated levels of GR expression in tumours were strongly linked to a more favourable outcome, while worse long-term survival and more recurrence are expected in ER- and TN tumours with greater expression of GR8–10. The gene discussed is NR3C1; the disease is breast carcinoma.